These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
534 related articles for article (PubMed ID: 26476374)
1. Quercetin reverses experimental pulmonary arterial hypertension by modulating the TrkA pathway. He Y; Cao X; Liu X; Li X; Xu Y; Liu J; Shi J Exp Cell Res; 2015 Nov; 339(1):122-34. PubMed ID: 26476374 [TBL] [Abstract][Full Text] [Related]
2. Involvement of Gax gene in hypoxia-induced pulmonary hypertension, proliferation, and apoptosis of arterial smooth muscle cells. Xia S; Tai X; Wang Y; An X; Qian G; Dong J; Wang X; Sha B; Wang D; Murthi P; Kalionis B; Wang X; Bai C Am J Respir Cell Mol Biol; 2011 Jan; 44(1):66-73. PubMed ID: 20160044 [TBL] [Abstract][Full Text] [Related]
3. Endothelin-1 driven proliferation of pulmonary arterial smooth muscle cells is c-fos dependent. Biasin V; Chwalek K; Wilhelm J; Best J; Marsh LM; Ghanim B; Klepetko W; Fink L; Schermuly RT; Weissmann N; Olschewski A; Kwapiszewska G Int J Biochem Cell Biol; 2014 Sep; 54():137-48. PubMed ID: 25016214 [TBL] [Abstract][Full Text] [Related]
4. Bioactive fraction of Rhodiola algida against chronic hypoxia-induced pulmonary arterial hypertension and its anti-proliferation mechanism in rats. Nan X; Su S; Ma K; Ma X; Wang X; Zhaxi D; Ge R; Li Z; Lu D J Ethnopharmacol; 2018 Apr; 216():175-183. PubMed ID: 29325918 [TBL] [Abstract][Full Text] [Related]
5. Up-regulation of caveolin-1 by DJ-1 attenuates rat pulmonary arterial hypertension by inhibiting TGFβ/Smad signaling pathway. Gao W; Shao R; Zhang X; Liu D; Liu Y; Fa X Exp Cell Res; 2017 Dec; 361(1):192-198. PubMed ID: 29069575 [TBL] [Abstract][Full Text] [Related]
6. Protective effects of dioscin on vascular remodeling in pulmonary arterial hypertension via adjusting GRB2/ERK/PI3K-AKT signal. Yang Y; Yin L; Zhu M; Song S; Sun C; Han X; Xu Y; Zhao Y; Qi Y; Xu L; Peng JY Biomed Pharmacother; 2021 Jan; 133():111056. PubMed ID: 33378960 [TBL] [Abstract][Full Text] [Related]
7. CTRP9 regulates hypoxia-mediated human pulmonary artery smooth muscle cell proliferation, apoptosis and migration via TGF-β1/ERK1/2 signaling pathway. Li YX; Run L; Shi T; Zhang YJ Biochem Biophys Res Commun; 2017 Sep; 490(4):1319-1325. PubMed ID: 28688765 [TBL] [Abstract][Full Text] [Related]
8. Intermedin modulates hypoxic pulmonary vascular remodeling by inhibiting pulmonary artery smooth muscle cell proliferation. Mao SZ; Fan XF; Xue F; Chen R; Chen XY; Yuan GS; Hu LG; Liu SF; Gong YS Pulm Pharmacol Ther; 2014 Feb; 27(1):1-9. PubMed ID: 23796770 [TBL] [Abstract][Full Text] [Related]
9. [Effects of docosahexaenoic acid on hypoxia-induced pulmonary arterial hypertension]. Chen R; Liu P; Yan J; Gu Y Zhonghua Jie He He Hu Xi Za Zhi; 2014 Feb; 37(2):109-12. PubMed ID: 24796591 [TBL] [Abstract][Full Text] [Related]
10. Selenoprotein P Promotes the Development of Pulmonary Arterial Hypertension: Possible Novel Therapeutic Target. Kikuchi N; Satoh K; Kurosawa R; Yaoita N; Elias-Al-Mamun M; Siddique MAH; Omura J; Satoh T; Nogi M; Sunamura S; Miyata S; Saito Y; Hoshikawa Y; Okada Y; Shimokawa H Circulation; 2018 Aug; 138(6):600-623. PubMed ID: 29636330 [TBL] [Abstract][Full Text] [Related]
11. Bioactive Compounds From Coptidis Rhizoma Alleviate Pulmonary Arterial Hypertension by Inhibiting Pulmonary Artery Smooth Muscle Cells' Proliferation and Migration. Luo S; Kan J; Zhang J; Ye P; Wang D; Jiang X; Li M; Zhu L; Gu Y J Cardiovasc Pharmacol; 2021 Aug; 78(2):253-262. PubMed ID: 34554677 [TBL] [Abstract][Full Text] [Related]
13. Critical role for the advanced glycation end-products receptor in pulmonary arterial hypertension etiology. Meloche J; Courchesne A; Barrier M; Carter S; Bisserier M; Paulin R; Lauzon-Joset JF; Breuils-Bonnet S; Tremblay É; Biardel S; Racine C; Courture C; Bonnet P; Majka SM; Deshaies Y; Picard F; Provencher S; Bonnet S J Am Heart Assoc; 2013 Jan; 2(1):e005157. PubMed ID: 23525442 [TBL] [Abstract][Full Text] [Related]
14. Salidroside attenuates chronic hypoxia-induced pulmonary hypertension via adenosine A2a receptor related mitochondria-dependent apoptosis pathway. Huang X; Zou L; Yu X; Chen M; Guo R; Cai H; Yao D; Xu X; Chen Y; Ding C; Cai X; Wang L J Mol Cell Cardiol; 2015 May; 82():153-66. PubMed ID: 25772255 [TBL] [Abstract][Full Text] [Related]
15. Isoquercitrin protects against pulmonary hypertension via inhibiting PASMCs proliferation. Zhang Y; Cui Y; Deng W; Wang H; Qin W; Huang C; Li C; Zhang J; Guo Y; Wu D; Guo H Clin Exp Pharmacol Physiol; 2017 Mar; 44(3):362-370. PubMed ID: 27873355 [TBL] [Abstract][Full Text] [Related]
16. P21-dependent protective effects of a carbon monoxide-releasing molecule-3 in pulmonary hypertension. Abid S; Houssaïni A; Mouraret N; Marcos E; Amsellem V; Wan F; Dubois-Randé JL; Derumeaux G; Boczkowski J; Motterlini R; Adnot S Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):304-12. PubMed ID: 24334871 [TBL] [Abstract][Full Text] [Related]
17. Exogenous spermine inhibits the proliferation of human pulmonary artery smooth muscle cells caused by chemically-induced hypoxia via the suppression of the ERK1/2- and PI3K/AKT-associated pathways. Wei C; Li HZ; Wang YH; Peng X; Shao HJ; Li HX; Bai SZ; Lu XX; Wu LY; Wang R; Xu CQ Int J Mol Med; 2016 Jan; 37(1):39-46. PubMed ID: 26572277 [TBL] [Abstract][Full Text] [Related]
18. Involvement of the bone morphogenetic protein system in endothelin- and aldosterone-induced cell proliferation of pulmonary arterial smooth muscle cells isolated from human patients with pulmonary arterial hypertension. Yamanaka R; Otsuka F; Nakamura K; Yamashita M; Otani H; Takeda M; Matsumoto Y; Kusano KF; Ito H; Makino H Hypertens Res; 2010 May; 33(5):435-45. PubMed ID: 20186146 [TBL] [Abstract][Full Text] [Related]
19. Baicalin inhibits hypoxia-induced pulmonary artery smooth muscle cell proliferation via the AKT/HIF-1α/p27-associated pathway. Zhang L; Pu Z; Wang J; Zhang Z; Hu D; Wang J Int J Mol Sci; 2014 May; 15(5):8153-68. PubMed ID: 24821539 [TBL] [Abstract][Full Text] [Related]
20. Hypoxia- or PDGF-BB-dependent paxillin tyrosine phosphorylation in pulmonary hypertension is reversed by HIF-1α depletion or imatinib treatment. Veith C; Zakrzewicz D; Dahal BK; Bálint Z; Murmann K; Wygrecka M; Seeger W; Schermuly RT; Weissmann N; Kwapiszewska G Thromb Haemost; 2014 Dec; 112(6):1288-303. PubMed ID: 25231004 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]